Donna Ford-Serbu

EvoEndo, Inc. is a medical device company that specializes in developing systems for unsedated endoscopic procedures. The company is based in Englewood, CO. The company's technology combines sterile single-use, flexible endoscopes and VR-based patient entertainment to reduce complexity, cost, and patient/provider apprehension. The company's system allows pediatric patients and adults to receive routine endoscopies without the use of general or sedation. The company was founded by Joel Friedlander, Robin Deterding, Emily DeBoer, and Jeremy Prager. Jonathan T. Hartmann has been the CEO of the company since 2023.

Eximis Surgical, Inc. develops and manufactures surgical devices. It offers XCor, a specimen removal device that reduce surgery times and risks associated with traditional tissue removal methods. The company was founded by Donna Ford-Serbu, Kristin D. Johnson, William Gregg, and Dirk Johnson on June 5, 2014 and is headquartered in Louisville, CO.

Eximis Surgical, Inc. develops and manufactures surgical devices. It offers XCor, a specimen removal device that reduce surgery times and risks associated with traditional tissue removal methods. The company was founded by Donna Ford-Serbu, Kristin D. Johnson, William Gregg, and Dirk Johnson on June 5, 2014 and is headquartered in Louisville, CO.

EvoEndo, Inc. is a medical device company that specializes in developing systems for unsedated endoscopic procedures. The company is based in Englewood, CO. The company's technology combines sterile single-use, flexible endoscopes and VR-based patient entertainment to reduce complexity, cost, and patient/provider apprehension. The company's system allows pediatric patients and adults to receive routine endoscopies without the use of general or sedation. The company was founded by Joel Friedlander, Robin Deterding, Emily DeBoer, and Jeremy Prager. Jonathan T. Hartmann has been the CEO of the company since 2023.

EvoEndo, Inc. is a medical device company that specializes in developing systems for unsedated endoscopic procedures. The company is based in Englewood, CO. The company's technology combines sterile single-use, flexible endoscopes and VR-based patient entertainment to reduce complexity, cost, and patient/provider apprehension. The company's system allows pediatric patients and adults to receive routine endoscopies without the use of general or sedation. The company was founded by Joel Friedlander, Robin Deterding, Emily DeBoer, and Jeremy Prager. Jonathan T. Hartmann has been the CEO of the company since 2023.

Eximis Surgical, Inc. develops and manufactures surgical devices. It offers XCor, a specimen removal device that reduce surgery times and risks associated with traditional tissue removal methods. The company was founded by Donna Ford-Serbu, Kristin D. Johnson, William Gregg, and Dirk Johnson on June 5, 2014 and is headquartered in Louisville, CO.

Eximis Surgical, Inc. develops and manufactures surgical devices. It offers XCor, a specimen removal device that reduce surgery times and risks associated with traditional tissue removal methods. The company was founded by Donna Ford-Serbu, Kristin D. Johnson, William Gregg, and Dirk Johnson on June 5, 2014 and is headquartered in Louisville, CO.

EvoEndo, Inc. is a medical device company that specializes in developing systems for unsedated endoscopic procedures. The company is based in Englewood, CO. The company's technology combines sterile single-use, flexible endoscopes and VR-based patient entertainment to reduce complexity, cost, and patient/provider apprehension. The company's system allows pediatric patients and adults to receive routine endoscopies without the use of general or sedation. The company was founded by Joel Friedlander, Robin Deterding, Emily DeBoer, and Jeremy Prager. Jonathan T. Hartmann has been the CEO of the company since 2023.

EvoEndo, Inc. is a medical device company that specializes in developing systems for unsedated endoscopic procedures. The company is based in Englewood, CO. The company's technology combines sterile single-use, flexible endoscopes and VR-based patient entertainment to reduce complexity, cost, and patient/provider apprehension. The company's system allows pediatric patients and adults to receive routine endoscopies without the use of general or sedation. The company was founded by Joel Friedlander, Robin Deterding, Emily DeBoer, and Jeremy Prager. Jonathan T. Hartmann has been the CEO of the company since 2023.